Brief: Medicamen Biotech Says Ethiopian FDA Conducted Audit Of Oncology Plant, Haridwar
26/03/2024 05:41
March 26 (Reuters) - Medicamen Biotech Ltd MEBI.NS :
* ETHIOPIAN FDA HAS CONDUCTED AUDIT OF ONCOLOGY PLANT,
HARIDWAR
* AWAITING PLANT APPROVAL FROM FDA
Source text for Eikon: ID:nBSE4STCHT
Further company coverage: MEBI.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medicamen Biotech
See all newsBrief: Medicamen Biotech Recommends Final Dividend Of 1 Rupee Per Share For FY Ended March 31, 2026
Brief: Medicamen Biotech Gets EU Approval For Registration Of “Paracetamol” From Denmark With XGX Pharma
India's Medicamen Biotech gains on US FDA nod for blood cancer drug
Brief: Medicamen Biotech Approves Allotment Of Shares, Warrants
India's Medicamen Biotech rises after deal with Denmark's XGX Pharma